Adalimumab Therapy for Patients With Crohn's Disease Who Are Unresponsive to or Intolerant of Infliximab

被引：0
|
作者：
Shafran, I [1 ]
Burgunder, P. [1 ]
Fakih, A. [1 ]
机构：
[1] Shafran Gastroenterol Ctr, Winter Pk, FL USA
来源：
INFLAMMATORY BOWEL DISEASES | 2009年 / 15卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [1] Efficacy of Adalimumab Therapy in Patients with Crohn's Disease Who Were Unresponsive to or Intolerant of Infliximab: Six Years of Experience in a Single Gastroenterology Center
    Shafran, Ira
    Cangemi, David
    Burgunder, Patricia
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S444 - S444
  • [2] Efficacy of adalimumab therapy in patients with Crohn's disease who were unresponsive to or intolerant of infliximab: 6 years of experience in a single gastroenterology center.
    Shafran, I
    Cangemi, D.
    Burgunder, P.
    [J]. INFLAMMATORY BOWEL DISEASES, 2011, 17 : S62 - S63
  • [3] Remission and clinical response to adalimumab at 4 weeks in patients with active luminal Crohn's disease who had lost response to or were intolerant of infliximab therapy
    Hinojosa, Joaquin
    Garcia, S.
    Esteve, M.
    Garcia, V.
    Martinez, P.
    Obrador, A.
    Gassull, M. A.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S455 - S456
  • [4] Efficacy of adalimumab in patients with Crohn's disease and failure to infliximab therapy: a clinical series
    Cordero Ruiz, Patricia
    Castro Marquez, Cristina
    Mendez Rufian, Vanesa
    Castro Laria, Luisa
    Caunedo Alvarez, Angel
    Romero Vazquez, Javier
    Herrerias Gutierrez, Juan Manuel
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2011, 103 (06) : 294 - 298
  • [5] Commentary: infliximab or adalimumab in Crohn's disease?
    Sprakes, M. B.
    Hamlin, P. J.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (04) : 398 - 398
  • [6] Evaluation of adalimumab therapy in multidisciplinary strategy for perianal Crohn's disease patients with infliximab failure
    Echarri, Ana
    Castro, Javier
    Barreiro, Manuel
    Carpio, Daniel
    Pereira, Santos
    Lorenzo, Aurelio
    [J]. JOURNAL OF CROHNS & COLITIS, 2010, 4 (06): : 654 - 660
  • [7] Adalimumab is effective in patients with fistulizing Crohn's disease who were primary nonresponders to infliximab treatment
    Lichtiger, Simon
    Binion, David
    Wolf, Douglas
    Present, Daniel
    Lomax, Kathleen
    Rafiq, Shuvobrata
    Holdbrook, Fred
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S416 - S416
  • [8] A retrospective comparison of infliximab versus adalimumab as induction therapy for crohn's disease
    Varma, P.
    Huang, C.
    Paul, E.
    Headon, B.
    Sparrow, M.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 108 - 109
  • [9] ECONOMIC EVALUATION OF INFLIXIMAB AND ADALIMUMAB FOR CROHN'S DISEASE
    Hughes, D. A.
    Kikuchi, T.
    Bodger, K.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A59 - A59
  • [10] Infliximab vs. Adalimumab for Crohn's disease
    Mulani, P.
    Chao, J.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (10) : 1265 - 1266
12345